Click here to view the United Healthcare (UHC) Medical Policy Updates » March 2025 United…
BCBS Louisiana Medical Policy Updates – October 2023
Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »
October 2023 BCBS Louisiana Medical Policy Updates:
- Actigraphy
- afamelanotide (Scenesse®)
- Amniotic Membrane and Amniotic Fluid
- avatrombopag (Doptelet®)
- bempedoic acid Products (Nexletol™, Nexlizet™)
- bimatoprost Implant (Durysta™)
- Bioengineered Skin and Soft Tissue Substitutes
- Botulinum Toxins
- Bronchial Thermoplasty for Asthma (Alair®)
- C1 Esterase Inhibitor (Berinert®)
- Cardiovascular Risk Panels
- Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)
- Cochlear Implant
- Confocal Laser Endomicroscopy
- Continuous Glucose Monitoring
- Cromolyn Nebulized Solution
- Deep Brain Stimulation
- deflazacort (Emflaza™)
- dextromethorphan/quinidine (Nuedexta®)
- difelikefalin (Korsuva )
- Electronic Brachytherapy for Nonmelanoma Skin Cancer
- Endovascular Therapies for Extracranial Vertebral Artery Disease
- Experimental-Investigational Services
- fostamatinib (Tavalisse™)
- Gene Expression Profile Testing and Circulating Tumor DNA Testing for Predicting Recurrence in Colon Cancer
- Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer
- Genetic Testing for Diagnosis and Management of Mental Health Conditions
- Genetic Testing for Mitochondrial Disorders
- Genetic Testing for Statin-Induced Myopathy
- Genetic Testing to Select Melanoma or Glioma Patients for Targeted Therapy
- Genotype-Guided Tamoxifen Treatment
- Genotype-Guided Warfarin Dosing
- Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
- Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Immune Prophylaxis for Respiratory Syncytial Virus
- Implantable Infusion Pump for Pain and Spasticity
- infliximab-axxq (Avsola®)
- insulin glargine-yfgn (Semglee™, biosimilar)
- Interspinous Fixation (Fusion) Devices
- KIF6 Genotyping for Predicting Cardiovascular Risk and/or Effectiveness of Statin Therapy
- Lipid Apheresis
- lusutrombopag (Mulpleta®)
- mecamylamine (Vecamyl®)
- Mechanical Stretch Devices for Joint Stiffness and Contractures
- Medical Management of Obstructive Sleep Apnea Syndrome
- methergine/methylergonovine tablets
- Molecular Analysis (Including Liquid Biopsy) for Targeted Therapy or Immunotherapy of Non-Small-Cell Lung Cancer
- Molecular Markers in Fine Needle Aspirates of the Thyroid
- Navigated Transcranial Magnetic Stimulation
- Neurodiagnostics
- nitrofurantoin 25 mg capsules (generic, Macrodantin®)
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Novel Medications for the Treatment of Uterine Fibroids
- ofatumumab (Kesimpta®)
- Orthopedic Applications of Platelet-Rich Plasma
- osilodrostat (Isturisa®)
- oxybate Products (Xyrem®, Xywav™)
- peanut (Arachis hypogaea) allergen powder-dnfp (Palforzia™)
- Proteogenomic Testing for Patients With Cancer
- Repository Corticotropin Injection
- riluzole (Tiglutik™, Exservan™)
- Select buprenorphine/naloxone Combination Products
- Select Erectile Dysfunction Medications
- Select Fenofibrate Products
- Select Muscle Relaxants
- Select Octreotide Medications
- Select Topical Antibiotics/Combinations
- Select Vascular Endothelial Growth Factor (VEGF) Inhibit and Combination Products
- Semi-Implantable and Fully Implantable Middle Ear Hearing Aids
- Temporomandibular Joint Dysfunction
- teprotumumab-trbw (Tepezza™)
- Topical Anesthetics
- Topical Antifungals
- Topical Pain Patches
- Transcatheter Pulmonary Valve Implantation
- Treatment of Hyperhidrosis
- Treatment of Varicose Veins/Venous Insufficiency
- Zerviate™ (cetirizine ophthalmic solution)
- Zileuton Products (Zyflo® /zileuton ER)
Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
